LATENT TUBERCULOSIS INFECTION IN YOUNG REFUGEES AND ASYLUM SEEKING MIGRANTS; A MULTICENTRE CROSS-SECTIONAL STUDY

ESPID Education, Maya Mueller-Hermelink, 179663

IMMUNOGENICITY OF DIFFERENT DOSING SCHEDULES OF TRIVALENT INFLUENZA VACCINE IN HIV-INFECTED PREGNANT WOMEN: A RANDOMIZED CONTROLLED TRIAL

ESPID Education, Marta S.C. Nunes, 179652

FIRST OUTBREAK OF ENTEROVIRUS RELATED BRAINSTEM ENCEPHALITIS IN WESTERN EUROPE: CHARACTERIZATION, MANAGEMENT AND EVOLUTION OF THE PATIENTS

ESPID Education, Núria Worner Tomasa, 179647

IMMUNOLOGICAL RESPONSE TO TREATMENT IN HIV-INFECTED MIGRANT CHILDREN IN EUROPE AS COMPARED TO DOMESTIC-BORN COUNTERPARTS

ESPID Education, Malte Kohns, 179662

IMPACT OF A CARBAPENEM ANTIMICROBIAL STEWARDSHIP PROGRAMME ON PATIENT OUTCOMES IN A WOMEN’S AND CHILDREN’S HOSPITAL

ESPID Education, Xue Fen Valerie Seah, 179656

New respiratory viruses

ESPID Education, Adam Meijer, 179646

Vaccination programmes in refugee camps

ESPID Education, Markus Hufnagel, 179661

Treatment of MDR enterobacteria

ESPID Education, Jesús Rodríguez-Baño, 179655

Enterovirus/parechovirus

ESPID Education, Heli Harvala, 179645

Immunisation during pregnancy

ESPID Education, Flor Muñoz, 179650

Antimicrobial stewardship in children

ESPID Education, Theoklis Zaoutis, 179654

Antibiotic-resistant pathogens in refugee children

ESPID Education, Daniel Glikman, 179660

MARKERS OF RISK TO DEVELOP A SEVERE INFECTION IN CHILDREN WITH FEVER AND NEUTROPENIA RELATED TO CHEMOTHERAPY

ESPID Education, Jesus Saavedra-Lozano, 179638

ANTIBODY ADMINISTRATION EFFECTIVELY TREATS PERTUSSIS IN A BABOON DISEASE MODEL AND PROVIDES FIVE WEEKS OF PERTUSSIS PROPHYLAXIS IN NEWBORN BABOONS

ESPID Education, Jennifer Maynard, 179644

EARLY TREATMENT OF CHAGAS DISEASE PREVENTS CONGENITAL TRANSMISSION.

ESPID Education, Jaime Altcheh, 184348

VIRAL KINETICS AND TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN IMMUNOCOMPROMISED CHILDREN

ESPID Education, Ben Margetts, 179637

NEGATIVE CYTOMEGALOVIRUS PCR IN NEONATAL DRIED BLOOD SPOTS: CAN WE RULE CONGENITAL INFECTION OUT? A STUDY FROM THE SPANISH REGISTRY (REDICCMV)

ESPID Education, Isabel Vives-Oñós, 179627

MOLECULAR BACTERIOLOGICAL SURVEILLANCE OF PAEDIATRIC ENTERIC FEVER IN NEPAL BETWEEN 2008 AND 2015

ESPID Education, Carl Britto, 179631

PERTUSSIS ANTIBODIES IN ENTIRE POPULATION, AMONG PATIENTS WITH PERTUSSIS AND THE TIME COURSE UP TO THREE YEARS AFTER THE DISEASE

ESPID Education, Piia Jõgi, 179642

CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION OF INVASIVE VIRIDANS GROUP STREPTOCOCCI INFECTIONS IN CHILDREN WITH CANCER, FEVER AND NEUTROPENIA, SANTIAGO, CHILE, 2004-2015

ESPID Education, María Carolina Rivacoba Rojas, 179635

Immunsing pregnant women – success and challenges

ESPID Education, Gayatri Amirthalingam, 179641

Congenital CMV

ESPID Education, Tiziana Lazzarotto, 179626

Viral infection in the child with HSCT

ESPID Education, Janet Englund, 179634

The search for a better pertussis vaccine

ESPID Education, Camille Locht, 179640

Typhoid disease burden

ESPID Education, John Crump, 179629

Risk factors in the neutropenic child

ESPID Education, Maria Elena Santolaya, 179633

Global Pertussis Initiative

ESPID Education, Stanley Plotkin, 179639

Future treatments for early treated HIV-infected children

ESPID Education, Jintanat Ananworanich, 179623

Immunological characteristics in early treated HIV-infected children

ESPID Education, Nigel Klein, 179622

Multi-level microbial biology in the light of evolution

ESPID Education, Fernando Baquero, 179619

DESCRIPTION OF PREVALENCE OF SYMPTOMS RELATED ZIKA VIRUS IN PREGNANT WOMEN WITH CHILDREN WITH MICROCEPHALY DURING THE FIRST YEAR OF EPIDEMIC IN PERNAMBUCO/BRAZIL

ESPID Education, Luiza Mello, 179617

Zika

ESPID Education, Karin Nielsen, 179616

Dengue

ESPID Education, Elisabeth Barnett, 179615

Chinkungunya

ESPID Education, Marco Safadi, 179614

INCREASING VACCINE COVERAGE - BARRIERS AND ATTITUDES

ESPID Education, Robb Butler, 134427

GETTING VACCINATED - ACCESS AND ATTITUDES

ESPID Education, Irina Ljungqvist, 134426

COMPARISON OF CHILDREN TESTING NEGATIVE AND POSITIVE FOR EBOLA VIRUS DISEASE IN EBOLA HOLDING UNITS, SIERRA LEONE

ESPID Education, Felicity Fitzgerald, 132227

RTSS MALARIA VACCINE., DOES IT WORK? IS IT SAFE?

ESPID Education, Brian Greenwood, 132228

TO LP OR NOT TO LP: SAFETY OF LUMBAR PUNCTURE IN COMATOSE CHILDREN WITH CLINCIAL FEATURES OF CEREBRAL MALARIA

ESPID Education, Christopher Moxon, 132229

REFUGEES ARRIVING IN EUROPE: THE MUNICH PAEDIATRIC INFECTION EXPERIENCE

ESPID Education, Ulrich von Both, 132230

VACCINE HESITANCY - THE EMERGENCE OF GLOBAL MISUNDERSTANDING

ESPID Education, Emilie Karafillakis, 134428

RSV - NEW THERAPEUTIC HORIZONS BRING CLINICAL CHALLENGES

ESPID Education, Steve Cunningham, 132215

SEASONAL AND PANDEMIC INFLUENZA IN PAEDIATRIC INTENSIVE CARE UNITS IN ENGLAND AND WALES: RISK FACTORS FOR ADMISSION AND MORTALITY

ESPID Education, Pia Hardelid, 132216

DIAGNOSIS AND PATHOPHYSIOLOGY OF BIOFILM INFECTIONS IN CYSTIC FIBROSIS

ESPID Education, Niels Hoeiby, 132217

DEXAMETHASONE FOR PLEURAL INFECTION IN CHILDREN: A DOUBLE BLIND, RANDOMIZED, CLINICAL TRIAL OF EFFICACY AND SAFETY

ESPID Education, ALFREDO TAGARRO, 132218

NASOPHARYNGEAL BACTERIAL DENSITY IS INCREASED BY VIRAL RESPIRATORY INFECTIONS WHICH MAY FACILITATE TRANSMISSION

ESPID Education, Valtyr Thors, 132219

HIGHLIGHTS & LESSONS FROM THE FIRST 17 YEARS OF THE BRIGHTON COLLABORATION

ESPID Education, Jan Bonhoeffer, 132220

ENHANCING VACCINE SAFETY CAPACITY GLOBALLY: A LIFECYCLE PERSPECTIVE

ESPID Education, Robert Chen, 132221

NO ASSOCIATION OF THE TEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) WITH PREVIOUSLY SUGGESTED PCV SAFETY SIGNALS

ESPID Education, Arto A Palmu, 132222

INFLUENZA VACCINATION IN CHILDREN WITH CYSTIC FIBROSIS USING INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE: EXPERIENCE FROM AN AUSTRIAN PAEDIATRIC HOSPITAL

ESPID Education, Sabine Renner, 132223

EXPLORING INCIDENCE RATES OF GUILLIAIN BARR

ESPID Education, Jozica Skufca, 132224

MEASUREMENT OF FEVER AFTER INFANT IMMUNISATIONS: COMPARISON OF INTERMITTENT AND 24 HOURS CONTINUOUS MONITORING

ESPID Education, Marta Valente Pinto, 132225

USING SMS TECHNOLOGY FOR REAL-TIME SURVEILLANCE OF ADVERSE EVENTS FOLLOWING IMMUNISATION

ESPID Education, Darren Westphal, 132226

THE RESURGENCE OF PERTUSSIS: FACTS, FICTION, MYTHS AND MISCONCEPTIONS?

ESPID Education, James Cherry, 132214

BILL MARSHALL LECTURE & AWARD: INTRODUCTION

ESPID Education, Adam Finn, 135835

ESCAPETB PROJECT -ENVIRONMENTAL SURVEILLANCE IN CANADA AND CAPE TOWN - IMPROVING OUR UNDERSTANDING OF AIRBORNE PATHOGEN EXPOSURE WITH A FOCUS ON TRANSMISSION OF ROD-SHAPED (MYCO-)BACTERIA)

ESPID Education, Koen Vanden Driessche, 132208

DISCOVERY OF IMMUNODOMINANT B CELL EPITOPES WITHIN SURFACE PNEUMOCOCCAL VIRULENCE PROTEINS IN PEDIATRIC PATIENTS WITH INVASIVE PNEUMOCOCCAL DISEASE

ESPID Education, Theano Lagousi, 132206

IMMUNOGENICITY OF REDUCED DOSE PRIMING SCHEDULES OF SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE FOLLOWED BY BOOSTER AT 12 MONTHS IN INFANTS: OPEN LABEL RANDOMISED CONTROLLED TRIAL

ESPID Education, David Pace, 132205

HOW DOES THE GUT-MICROBIOTA INFLUENCE THE ONSET AND NATURE OF JUVENILE IDIOPATHIC ARTHRITIS?

ESPID Education, Paula Sanchez-Moreno, 132203

ZIKA VÍRUS AND GESTATION: FIRST CASES DETECTED IN SERGIPE

ESPID Education, Eitan Berezin, 132197

EARLY ANTIRETROVIRAL THERAPY PRESERVES THYMIC OUTPUT IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: EVIDENCE FROM THE CHILDREN WITH HIV EARLY ANTIRETROVIRAL THERAPY (CHER) TRIAL

ESPID Education, Helen Payne, 132198

PROTECTING AGAINST THE CHANGELING DEMON AND THE TROLL OF TRANSPLANTATION

ESPID Education, Stanley Plotkin, 132199

USING BIOMARKERS TO GUIDE MANAGEMENT IN THE EMERGENCY DEPARTMENT

ESPID Education, Alain Gervaix, 132182

CLINICAL SIGNS AND POINT OF CARE TESTING IN FEBRILE CHILDREN

ESPID Education, Henriette Moll, 132183

PREVENTING EBOLA - THE RING VACCINATION STUDY

ESPID Education, Ana Maria Henao-Restrepo, 132187

NEUROLOGICAL AND AUTOIMMUNE COMPLICATIONS OF ZIKA VIRUS INFECTION

ESPID Education, Marco Safadi, 132188

A PRACTICAL GUIDE TO GETTING THE DOSE RIGHT

ESPID Education, Roger Brüggemann, 132189

PHARMACOKINETIC (PK) MODELLING OF MEROPENEM IN PLASMA AND CEREBROSPINAL FLUID (CSF) IN INFANTS WITH LATE-ONSET SEPSIS (LOS) AND/OR BACTERIAL MENINGITIS

ESPID Education, Eva Germovsek, 132190

PHARMACOMETRIC MODELS AND IN SILICO STUDIES

ESPID Education, Marc Pfister, 132192

POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF TEICOPLANIN IN NEONATES

ESPID Education, Virginia Ramos Martin, 132193

IS IMMUNISING CHILDREN REALLY THE BEST WAY TO PROTECT THE ELDERLY AGAINST FLU?

ESPID Education, Marc Baguelin, 132194

UNIVERSAL CHILDHOOD VARICELLA VACCINE - MODELLING AND ETHICAL CONSTRUCTS

ESPID Education, Philippe Beutels, 132195

EPIDEMIOLOGY AND VACCINE EFFECTIVENESS DURING A LARGE MUMPS OUTBREAK IN WESTERN AUSTRALIA

ESPID Education, Darren Westphal, 134425

CONTROL OF HIB IN CHILDREN: EPIDEMIOLOGY AND SEROPREVALENCE IN ENGLAND

ESPID Education, Sarah Collins, 134424

PROSPECTIVE VALIDATION OF LIPOCALIN-2 AS A PREDICTOR OF BACTERIAL INFECTION IN CHILDREN: A HOSPITAL-BASED STUDY.

ESPID Education, Climent Casals-Pascual, 132170

ADVANCES IN PATHOGEN DETECTION

ESPID Education, Mark Nicol, 132172

Diagnostics in a Digital Age: A Paediatric Perspective

ESPID Education, Rosanna Peeling, 132173

UNRAVELLING THE GENETICS OF MENINGOCOCCAL DISEASE: THE FACTOR H STORY REVISITED

ESPID Education, Sonia Maria Davila Dominguez, 132174

AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO VIRAL INFECTIONS

ESPID Education, Vanessa Sancho Shimizu, 132175

AN OVERVIEW OF GENETIC SUSCEPTIBILITY TO FUNGAL INFECTIONS

ESPID Education, Frank van de Veerdonk, 132176

PRAGMATIC COMMUNITY ANTIMICROBIAL TRIALS IN CHILDREN AND ADULTS

ESPID Education, Paul Little, 132177

MEROPENEM VS STANDARD OF CARE ANTIBIOTICS (SOC) FOR LATE ONSET NEONATAL SEPSIS (LOS): A RANDOMIZED CONTROLLED TRIAL NEOMERO-1

ESPID Education, Irja Lutsar, 132178

FEBRILE URINARY TRACT INFECTION DUE TO EXTENDED-SPECTRUM BETA-LACTAMASE-PRODUCING ENTEROBACTERIACEAE IN CHILDREN: AN OBSERVATIONAL FRENCH STUDY

ESPID Education, Fouad MADHI, 132179

ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN: IMPACT OF CLINICAL PROFILE AND CULTURAL BACKGROUND. A EUROPEAN OBSERVATIONAL STUDY IN EMERGENCY CARE.

ESPID Education, Rianne Oostenbrink, 132180

TOPICAL ANTIBIOTICS WORK!

ESPID Education, Roderick Venekamp, 132181

ACTIVATION OF THE INNATE IMMUNE SYSTEM AND ITS IMPLICATIONS FOR TREATMENT IN INFECTIOUS DISEASES

ESPID Education, Bruce Beutler, 132166

WHAT HAS THE RARE TAUGHT US ABOUT THE COMMON?

ESPID Education, Steve Holland, 132167

GENETIC INSIGHT INTO THE PERSISTENCE OF VACCINE-INDUCED IMMUNITY FOLLOWING CHILDHOOD IMMUNISATION

ESPID Education, Daniel O'connor, 132168

ESPID OPENING SYMPOSIUM - SHAPING THE FUTURE OF ANTIMICROBIAL AND VACCINE RESEARCH AND DEVELOPMENT

ESPID Education, Session Speakers, 136517

MECHANISMS OF VIRAL VIRULENCE IN RESPONSE TO HUMAN NUTRITION

ESPID Education, Melinda Beck, 132159

HOST-PARASITE INTERACTIONS IN RELATION TO NUTRITIONAL STATUS AND THE IMPLICATIONS FOR THE WIDER SCIENTIFIC COMMUNITY

ESPID Education, Donald Bundy, 132160

MICAFUNGIN ALTERS THE AMINO ACID, NUCLEIC ACID, AND CENTRAL CARBON METABOLOMIC PROPERTIES OF CANDIDA ALBICANS AT SUBINHIBITORY CONCENTRATIONS: NOVEL INSIGHTS INTO MECHANISMS OF ACTION

ESPID Education, Aspasia Katragkou, 132161

INFECTION AND NUTRITION

ESPID Education, Alan Jackson, 135833

PREVENTION OF ANTIMICROBIAL RESISTANCE IN THE CLINIC

ESPID Education, Jan A.J.W. Kluytmans, 99555

MECHANISMS OF ANTIMICROBIAL RESISTANCE

ESPID Education, Pentti Huovinen, 99551

Chair

ESPID Education, Adam Finn, 99547

Pertussis? a never ending story?

ESPID Education, Ulrich Heininger, 99548

The effects of LAIV on bacterial colonisation of the nasopharynx in young healthy children: A randomised controlled study

ESPID Education, Thors Valtyr, 99546

Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

ESPID Education, James Seddon, 99545

Lumpers versus splitters in Streptococcus pyogenes classification: Impact on vaccine development and molecular typing

ESPID Education, Pierre Smeesters, 99544